nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0645	0.0671	CcSEcCtD
Guanfacine—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0321	0.0334	CcSEcCtD
Guanfacine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0251	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0229	0.0238	CcSEcCtD
Guanfacine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0224	0.0233	CcSEcCtD
Guanfacine—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0225	CcSEcCtD
Guanfacine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0213	0.0221	CcSEcCtD
Guanfacine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0199	0.0208	CcSEcCtD
Guanfacine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0205	CcSEcCtD
Guanfacine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0205	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0191	0.0198	CcSEcCtD
Guanfacine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0194	CcSEcCtD
Guanfacine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0173	0.018	CcSEcCtD
Guanfacine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0179	CcSEcCtD
Guanfacine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.017	0.0177	CcSEcCtD
Guanfacine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0171	CcSEcCtD
Guanfacine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0163	0.017	CcSEcCtD
Guanfacine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0169	CcSEcCtD
Guanfacine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.016	0.0166	CcSEcCtD
Guanfacine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0158	CcSEcCtD
Guanfacine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.015	0.0156	CcSEcCtD
Guanfacine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0144	0.015	CcSEcCtD
Guanfacine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0145	CcSEcCtD
Guanfacine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0138	CcSEcCtD
Guanfacine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0133	CcSEcCtD
Guanfacine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0133	CcSEcCtD
Guanfacine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0132	CcSEcCtD
Guanfacine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0125	0.013	CcSEcCtD
Guanfacine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0128	CcSEcCtD
Guanfacine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0127	CcSEcCtD
Guanfacine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0126	CcSEcCtD
Guanfacine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.012	0.0125	CcSEcCtD
Guanfacine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0122	CcSEcCtD
Guanfacine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0122	CcSEcCtD
Guanfacine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0121	CcSEcCtD
Guanfacine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0115	0.012	CcSEcCtD
Guanfacine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0119	CcSEcCtD
Guanfacine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0115	CcSEcCtD
Guanfacine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0115	CcSEcCtD
Guanfacine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0115	CcSEcCtD
Guanfacine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.011	0.0115	CcSEcCtD
Guanfacine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0114	CcSEcCtD
Guanfacine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0113	CcSEcCtD
Guanfacine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0111	CcSEcCtD
Guanfacine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0111	CcSEcCtD
Guanfacine—Shock—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0109	CcSEcCtD
Guanfacine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0108	CcSEcCtD
Guanfacine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0107	CcSEcCtD
Guanfacine—CYP2C19—urine—nephrolithiasis	0.0103	0.26	CbGeAlD
Guanfacine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00992	0.0103	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00968	0.0101	CcSEcCtD
Guanfacine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00961	0.01	CcSEcCtD
Guanfacine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00954	0.00993	CcSEcCtD
Guanfacine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00947	0.00986	CcSEcCtD
Guanfacine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00944	0.00983	CcSEcCtD
Guanfacine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00935	0.00973	CcSEcCtD
Guanfacine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00923	0.00961	CcSEcCtD
Guanfacine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00916	0.00953	CcSEcCtD
Guanfacine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00908	0.00946	CcSEcCtD
Guanfacine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00875	0.00911	CcSEcCtD
Guanfacine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00868	0.00904	CcSEcCtD
Guanfacine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0084	0.00874	CcSEcCtD
Guanfacine—CYP2C9—urine—nephrolithiasis	0.00796	0.201	CbGeAlD
Guanfacine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00782	0.00815	CcSEcCtD
Guanfacine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00762	0.00793	CcSEcCtD
Guanfacine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00751	0.00782	CcSEcCtD
Guanfacine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00757	CcSEcCtD
Guanfacine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00731	CcSEcCtD
Guanfacine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00675	0.00703	CcSEcCtD
Guanfacine—Rash—Hydrochlorothiazide—nephrolithiasis	0.0067	0.00697	CcSEcCtD
Guanfacine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00669	0.00697	CcSEcCtD
Guanfacine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00665	0.00693	CcSEcCtD
Guanfacine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00657	CcSEcCtD
Guanfacine—CYP3A4—urine—nephrolithiasis	0.00607	0.153	CbGeAlD
Guanfacine—NISCH—nephron tubule—nephrolithiasis	0.00569	0.144	CbGeAlD
Guanfacine—NISCH—cortex of kidney—nephrolithiasis	0.00487	0.123	CbGeAlD
Guanfacine—ADRA2A—cortex of kidney—nephrolithiasis	0.00178	0.0449	CbGeAlD
Guanfacine—CYP3A4—renal system—nephrolithiasis	0.00148	0.0375	CbGeAlD
Guanfacine—CYP3A4—kidney—nephrolithiasis	0.00143	0.0363	CbGeAlD
